Dose-response and dose-toxicity relationships for yttrium-90 glass radioembolization in patients with colorectal cancer liver metastases

AA Alsultan, C van Roekel, MW Barentsz… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Purpose Radioembolization based on personalized treatment planning requires established
dose-response and dose-toxicity relationships. The aim of this study was to investigate dose …

Dose–response and dose–toxicity relationships for glass 90Y radioembolization in patients with liver metastases from colorectal cancer

AA Alsultan, C van Roekel, MW Barentsz… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Radioembolization based on personalized treatment planning requires established dose–
response and dose–toxicity relationships. The aim of this study was to investigate dose …

Insights into the dose–response relationship of radioembolization with resin 90Y-microspheres: a prospective cohort study in patients with colorectal cancer liver …

AF van den Hoven, CENM Rosenbaum… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Randomized controlled trials are investigating the benefit of hepatic radioembolization
added to systemic therapy in the first-and second-line treatment of patients with colorectal …

[HTML][HTML] Administered activity and outcomes of glass versus resin 90Y microsphere radioembolization in patients with colorectal liver metastases

SM Srinivas, EC Nasr, VK Kunam… - Journal of …, 2016 - ncbi.nlm.nih.gov
Background Given the differences in size, specific activity, and dosing methods for glass
yttrium-90 microspheres (90 Y-glass) and resin 90 Y microspheres (90 Y-resin), these …

Correlation between average absorbed dose and metabolic response in the radio-embolization of liver colorectal metastases with resin microspheres

A Dieudonné, A Aouf, A Sabet, C Meyer, B Simon… - 2015 - Soc Nuclear Med
1237 Objectives To highlight a dose-effect relationship in the treatment of liver colorectal
metastases with resin microspheres. Methods Retrospective analysis of 31 colorectal cancer …

Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin …

P Flamen, B Vanderlinden, P Delatte… - Physics in Medicine …, 2008 - iopscience.iop.org
Selective internal radiotherapy (SIRT) using Yttrium-90 labeled resin microspheres is
increasingly used for the radioembolization of unresectable liver metastases of colorectal …

90Y radioembolization of colorectal hepatic metastases using glass microspheres: safety and survival outcomes from a 531-patient multicenter study

R Hickey, RJ Lewandowski, T Prudhomme… - Journal of nuclear …, 2016 - Soc Nuclear Med
Hepatic metastases of colorectal carcinoma are a leading cause of cancer-related mortality.
Most colorectal liver metastases become refractory to chemotherapy and biologic agents, at …

Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre …

EM Triviño-Ibáñez, PP Moreno, JJC Dopazo… - Revista Española de …, 2022 - Elsevier
Objective To determine the therapeutic effectiveness and safety of transarterial
radioembolization (TARE) with Yttrium-90 in patients with colorectal cancer (CRC) liver …

[HTML][HTML] Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis

KP Willowson, AR Hayes, DLH Chan, M Tapner… - EJNMMI research, 2017 - Springer
Background The aim of this study was to investigate the relationship between absorbed
dose and response of colorectal cancer liver metastases treated with [90 Y]-resin …

Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG …

CO Wong, R Salem, F Qing, KT Wong… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Our aim was to assess the feasibility of using PET for quantifying metabolic response after
intraarterial 90Y-glass microspheres for metastatic colorectal cancer to the liver by …